A. Cinrg-investigators, A. Dubrovsky, K. Kornberg, M. North, R. Ryan et al.,

A. Connolly, R. T. Pestronk, E. K. Abresch, and N. C. Henricson,

C. M. Joyce, A. Mcdonald, H. Cnaan, L. P. Gordish-dressmsn, R. Morgenroth et al., Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population, Tina Duong References, vol.1, pp.3175-86, 2009.

V. Straub, P. Balabanov, K. Bushby, M. Ensini, N. Goemans et al., Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy, Lancet Neurol, vol.15, pp.882-90, 2016.

K. Bushby, R. Finkel, D. J. Birnkrant, L. E. Case, P. R. Clemens et al., Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management, Lancet Neurol, vol.9, pp.77-93, 2010.

J. A. Ellis, E. Vroom, and F. Muntoni, ENMC International Workshop: newborn screening for Duchenne muscular dystrophy 14-16th, Neuromuscul Disord, vol.23, pp.682-691, 2012.

A. Aartsma-rus, I. B. Ginjaar, and K. Bushby, The importance of genetic diagnosis for Duchenne muscular dystrophy, J Med Genet, vol.53, pp.145-51, 2016.

I. Desguerre, C. Christov, M. Mayer, R. Zeller, H. Becane et al., Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up, PLoS ONE, vol.4, p.4347, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00447998

F. Magri, A. Govoni, D. Angelo, M. G. , D. Bo et al., Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up, J Neurol, vol.258, pp.1610-1633, 2011.

E. K. Henricson, R. T. Abresch, A. Cnaan, F. Hu, T. Duong et al., The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other, Muscle Nerve, vol.48, pp.55-67, 2013.

E. Henricson, R. Abresch, J. J. Han, A. Nicorici, G. Keller et al., The 6-minute walk test and person-reported outcomes in boys with duchenne muscular dystrophy and typically developing controls: longitudinal comparisons and clinicallymeaningful changes over one year, PLoS Curr, 2013.

C. M. Mcdonald, E. K. Henricson, R. T. Abresch, J. M. Florence, M. Eagle et al., THE 6-minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study, Muscle Nerve, vol.48, pp.343-56, 2013.

C. M. Mcdonald, E. K. Henricson, R. T. Abresch, J. Florence, M. Eagle et al., The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study, Muscle Nerve, vol.48, pp.357-68, 2013.

E. S. Mazzone, S. Messina, G. Vasco, M. Main, M. Eagle et al., Reliability of the north star ambulatory assessment in a multicentric setting, Neuromuscul Disord, vol.19, pp.458-61, 2009.

E. Mazzone, G. Vasco, M. P. Sormani, Y. Torrente, A. Berardinelli et al., Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study, Neurology, vol.77, pp.250-256, 2011.

V. Ricotti, D. A. Ridout, M. Pane, M. Main, A. Mayhew et al., The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials, J Neurol Neurosurg Psychiatry, 2015.

J. C. Van-den-bergen, H. B. Ginjaar, E. H. Niks, A. Aartsma-rus, J. Van-den-bergen et al., Prolonged ambulation in Duchenne patients with a mutation amenable to exon 44 skipping, J Neuromuscul Dis, vol.1, pp.91-94, 2014.

L. Bello, A. Kesari, H. Gordish-dressman, A. Cnaan, L. P. Morgenroth et al., Genetic modifiers of ambulation in the cooperative international neuromuscular research group Duchenne natural history study, Ann Neurol, vol.77, pp.684-96, 2015.

K. Anthony, V. Arechavala-gomeza, V. Ricotti, S. Torelli, L. Feng et al., Biochemical characterization of patients with inframe or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping, JAMA Neurol, vol.71, p.32, 2014.

E. Pegoraro, E. P. Hoffman, L. Piva, B. F. Gavassini, S. Cagnin et al., SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy, Neurology, vol.76, pp.219-245, 2011.

K. M. Flanigan, E. Ceco, K. M. Lamar, Y. Kaminoh, D. M. Dunn et al., LTBP4 genotype predicts age of ambulatory loss in duchenne muscular dystrophy, Ann Neurol, vol.73, pp.481-489, 2013.

L. Bello, K. M. Flanigan, R. B. Weiss, U. Dystrophinopathy-project, P. Spitali et al., Association study of exon variants in the NF-?B and TGF? pathways identifies CD40 as a modifier of duchenne muscular dystrophy, Am J Hum Genet, vol.99, pp.1163-71, 2016.

L. Bello, L. Piva, A. Barp, A. Taglia, E. Picillo et al., Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy, Neurology, vol.79, pp.159-62, 2012.

J. C. Van-den-bergen, M. Hiller, S. Böhringer, L. Vijfhuizen, H. B. Ginjaar et al., Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants, J Neurol Neurosurg Psychiatry, vol.86, pp.1060-1065, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02436450

K. Lamar and E. M. Mcnally, Genetic modifiers for neuromuscular diseases, J Neuromuscul Dis, vol.1, pp.3-13, 2014.

R. B. Weiss, V. J. Vieland, D. M. Dunn, Y. Kaminoh, and K. M. Flanigan, Long-range genomic regulators of THBS1 and LTBP4 modify disease severity in duchenne muscular dystrophy, Ann Neurol, vol.84, pp.234-279, 2018.

F. Ifac, P. Taschner, G. Schaafsma, J. Celli, and J. Laros, the next generation in gene variant databases, Hum Mutat, vol.32, pp.557-63, 2011.

G. Lunter and M. Goodson, Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads, Genome Res, vol.21, pp.936-945, 2011.

H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan et al., The sequence alignment/Map format and SAMtools, Bioinformatics, vol.25, pp.2078-2087, 2009.

K. Wang, M. Li, and H. Hakonarson, ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data, Nucleic Acids Res, vol.38, p.164, 2010.

J. Taylor, A tail strength measure for assessing the overall univariate significance in a dataset, Biostatistics, vol.7, pp.167-81, 2005.

M. C. Wu, S. Lee, T. Cai, Y. Li, M. Boehnke et al., Rare-variant association testing for sequencing data with the sequence kernel association test, Am J Hum Genet, vol.89, pp.82-93, 2011.

S. Böhringer, Dynamic parallelization of R functions, R J, vol.5, pp.88-96, 2013.

J. J. Goeman, S. A. Van-de-geer, and H. C. Van-houwelingen, Testing against a high dimensional alternative, J R Stat Soc Ser B, vol.68, pp.477-93, 2006.

D. Stöckel, T. Kehl, P. Trampert, L. Schneider, C. Backes et al., Multi-omics enrichment analysis using the GeneTrail2 web service, Bioinformatics, vol.32, pp.1502-1510, 2016.

*. Consortium and . Tgte, The genotype-tissue expression (GTEx) project, Nat Genet, vol.45, p.580, 2013.

M. Kotlyar, C. Pastrello, N. Sheahan, and I. Jurisica, Integrated interactions database: tissue-specific view of the human and model organism interactomes, Nucleic Acids Res, vol.44, pp.536-577, 2016.

A. Elsharawy, C. Manaster, M. Teuber, P. Rosenstiel, R. Kwiatkowski et al., SNPSplicer: systematic analysis of SNPdependent splicing in genotyped cDNAs, Hum Mutat, vol.27, pp.1129-1163, 2006.

Z. Koeks, C. L. Bladen, D. Salgado-as, E. Van-zwet, O. Pogoryelova et al., Clinical outcomes in duchenne muscular dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database, J Neuromuscul Dis, vol.4, pp.293-306, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01779991

F. Muntoni, J. Domingos, A. Y. Manzur, A. Mayhew, M. Guglieri et al., Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy, PLoS ONE, vol.14, p.221097, 2019.

M. J. Emond, T. Louie, J. Emerson, W. Zhao, R. A. Mathias et al., Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis, Nat Genet, vol.44, pp.886-895, 2012.

P. Kumar, S. Henikoff, and P. C. Ng, Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm, Nat Protoc, vol.4, pp.1073-82, 2009.

I. A. Adzhubei, S. Schmidt, L. Peshkin, V. E. Ramensky, A. Gerasimova et al., A method and server for predicting damaging missense mutations, Nat Methods, vol.7, pp.248-257, 2010.

R. Petryszak, T. Burdett, B. Fiorelli, N. A. Fonseca, M. Gonzalez-porta et al., Expression Atlas update-A database of gene and transcript expression from microarray-and sequencing-based functional genomics experiments, Nucleic Acids Res, vol.42, 2014.

T. Rolland, M. Ta?an, B. Charloteaux, S. J. Pevzner, Q. Zhong et al., A proteome-scale map of the human interactome network, Cell, vol.159, pp.1212-1238, 2014.

M. Bakay, Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration, Brain, vol.129, pp.996-1013, 2006.

J. Van-setten, N. Verweij, H. Mbarek, M. N. Niemeijer, S. Trompet et al., Genome-wide association meta-analysis of 30,000 samples identifies seven novel loci for quantitative ECG traits, Eur J Hum Genet, pp.952-62, 2019.

, Hoffman 8 ? CINRG Investigators ? Zaida Koeks 11 ? H. Eka Suchiman 12 ? Sebahattin Cirak 2,13,14 ? Mariacristina Scoto 2 ? Mojgan Reza 4 ? Peter A. C. 't Hoen 1 ? Erik H, Niks 11 ? Sylvie Tuffery-Giraud 7 ? Hanns Lochmüller 4,15,16 ? Alessandra Ferlini 6 ? Francesco Muntoni 2,17 ? Annemieke Aartsma-Rus, vol.1, p.4